Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part III. Management of Advanced Differentiated Thyroid Cancers - Chapter 1-2. Locally Recurred/Persistent Thyroid Cancer Management Strategies 2024
10.11106/ijt.2024.17.1.147
- Author:
Ho-Ryun WON
1
;
Min Kyoung LEE
;
Ho-Cheol KANG
;
Bon Seok KOO
;
Hyungju KWON
;
Sun Wook KIM
;
Won Woong KIM
;
Jung-Han KIM
;
Young Joo PARK
;
Jun-Ook PARK
;
Young Shin SONG
;
Seung Hoon WOO
;
Chang Hwan RYU
;
Eun Kyung LEE
;
Joon-Hyop LEE
;
Ji Ye LEE
;
Cho Rok LEE
;
Dong-Jun LIM
;
Jae-Yol LIM
;
Yun Jae CHUNG
;
Kyorim BACK
;
Dong Gyu NA
;
Author Information
1. Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Sejong Hospital, Sejong, Korea
- Publication Type:REVIEW ARTICLES
- From:International Journal of Thyroidology
2024;17(1):147-152
- CountryRepublic of Korea
- Language:EN
-
Abstract:
These guidelines aim to establish the standard practice for diagnosing and treating patients with differentiated thyroid cancer (DTC). Based on the Korean Thyroid Association (KTA) Guidelines on DTC management, the “Treatment of Advanced DTC” section was revised in 2024 and has been provided through this chapter. Especially, this chapter covers surgical and nonsurgical treatments for the local (previous surgery site) or regional (cervical lymph node metastasis) recurrences. After drafting the guidelines, it was finalized by collecting opinions from KTA members and related societies. Surgical resection is the preferred treatment for local or regional recurrence of advanced DTC. If surgical resection is not possible, nonsurgical resection treatment under ultrasonography guidance may be considered as an alternative treatment for local or regional recurrence of DTC. Furthermore, if residual lesions are suspected even after surgical resection or respiratory-digestive organ invasion, additional radioactive iodine and external radiation treatments are considered.
